IL150633A0 - Asymmetric synthesis of pregabalin - Google Patents

Asymmetric synthesis of pregabalin

Info

Publication number
IL150633A0
IL150633A0 IL15063301A IL15063301A IL150633A0 IL 150633 A0 IL150633 A0 IL 150633A0 IL 15063301 A IL15063301 A IL 15063301A IL 15063301 A IL15063301 A IL 15063301A IL 150633 A0 IL150633 A0 IL 150633A0
Authority
IL
Israel
Prior art keywords
pregabalin
asymmetric synthesis
asymmetric
synthesis
Prior art date
Application number
IL15063301A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26874236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL150633(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL150633A0 publication Critical patent/IL150633A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
IL15063301A 2000-01-27 2001-01-11 Asymmetric synthesis of pregabalin IL150633A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17835900P 2000-01-27 2000-01-27
US19042700P 2000-03-17 2000-03-17
PCT/IB2001/000024 WO2001055090A1 (en) 2000-01-27 2001-01-11 Asymmetric synthesis of pregabalin

Publications (1)

Publication Number Publication Date
IL150633A0 true IL150633A0 (en) 2003-02-12

Family

ID=26874236

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15063301A IL150633A0 (en) 2000-01-27 2001-01-11 Asymmetric synthesis of pregabalin
IL150633A IL150633A (en) 2000-01-27 2002-07-08 Asymmetric synthesis of pragabalin and its new intermediates

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150633A IL150633A (en) 2000-01-27 2002-07-08 Asymmetric synthesis of pragabalin and its new intermediates

Country Status (50)

Country Link
US (1) US6891059B2 (es)
EP (1) EP1250311B1 (es)
JP (2) JP4235384B2 (es)
KR (1) KR100549748B1 (es)
CN (1) CN1210253C (es)
AP (1) AP1438A (es)
AR (1) AR028499A1 (es)
AT (1) ATE261930T1 (es)
AU (1) AU777046B2 (es)
BG (1) BG65560B1 (es)
BR (1) BRPI0107863B8 (es)
CA (1) CA2396090C (es)
CO (1) CO5251411A1 (es)
CR (1) CR6703A (es)
CU (1) CU23221A3 (es)
CY (1) CY2004011I1 (es)
CZ (1) CZ302838B6 (es)
DE (1) DE60102356T2 (es)
DK (1) DK1250311T3 (es)
DZ (1) DZ3268A1 (es)
EA (1) EA004934B1 (es)
EE (1) EE05216B1 (es)
EG (1) EG24138A (es)
ES (1) ES2219493T3 (es)
GE (1) GEP20043236B (es)
HN (1) HN2001000010A (es)
HR (1) HRP20020627B1 (es)
HU (1) HU228815B1 (es)
IL (2) IL150633A0 (es)
IS (1) IS2038B (es)
MA (1) MA26869A1 (es)
ME (1) ME00921B (es)
MX (1) MXPA02007307A (es)
MY (1) MY127152A (es)
NO (1) NO327958B1 (es)
NZ (1) NZ519551A (es)
OA (1) OA12167A (es)
PA (1) PA8510501A1 (es)
PE (1) PE20011063A1 (es)
PL (1) PL203985B1 (es)
PT (1) PT1250311E (es)
RS (1) RS50257B (es)
SI (1) SI1250311T1 (es)
SK (1) SK287303B6 (es)
SV (1) SV2002000295A (es)
TN (1) TNSN01016A1 (es)
TR (1) TR200400953T4 (es)
TW (1) TWI288128B (es)
UA (1) UA75584C2 (es)
WO (1) WO2001055090A1 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189872B1 (pl) 1996-07-24 2005-10-31 Warner Lambert Co Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
EP1250311B1 (en) * 2000-01-27 2004-03-17 Warner-Lambert Company Asymmetric synthesis of pregabalin
US6687187B2 (en) * 2000-08-11 2004-02-03 Phonak Ag Method for directional location and locating system
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
AU2005221401A1 (en) * 2004-03-12 2005-09-22 Warner-Lambert Company Llc C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
DK1831154T3 (da) 2004-06-21 2010-04-12 Warner Lambert Co Fremstilling af pregabalin og relaterede forbindelser
MX2007012396A (es) * 2005-04-06 2007-11-20 Teva Pharma Formas cristalinas de pregabalina.
CA2603215A1 (en) * 2005-04-11 2006-10-19 Teva Pharmaceutical Industries Ltd. Process for making (s)-pregabalin
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
ATE523484T1 (de) 2005-05-10 2011-09-15 Teva Pharma Optische lösung a us 3-carbamoylmethyl-5-methyl- hexansäure
KR20070067077A (ko) * 2005-05-10 2007-06-27 테바 파마슈티컬 인더스트리즈 리미티드 이소부틸글루타르산을 함유하지 않는 프레가발린 및 이의제조 방법
CA2604602A1 (en) 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Method for the preparation of pregabalin and salts thereof
US20060270871A1 (en) * 2005-05-30 2006-11-30 Khanduri Chandra H Polymorphic form i of pregabalin and processes for its preparation
CN100410242C (zh) * 2005-06-23 2008-08-13 江苏恩华药业股份有限公司 普瑞巴林中间体及其制备方法
WO2007035890A1 (en) 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. An asymmetric synthesis of ( s ) - ( + ) -3- (aminomethyl) -5-methylhexanoic acid
NL2000281C2 (nl) * 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
CA2646474A1 (en) * 2006-04-24 2007-11-08 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of 3-isobutylglutaric acid
WO2007139933A2 (en) * 2006-05-24 2007-12-06 Teva Pharmaceutical Industries Ltd. Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
BRPI0702897A2 (pt) * 2006-05-31 2011-03-15 Teva Pharmaceutical Ind Ltda processo para preparar um intermediário de pregabalina
WO2007143152A2 (en) * 2006-05-31 2007-12-13 Teva Pharmaceutical Industries Ltd. Preparation of (s)-pregabalin-nitrile
EP1903027A1 (en) * 2006-09-13 2008-03-26 Novartis AG Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of NEP inhibitors
EP2021318A2 (en) * 2007-03-22 2009-02-11 Teva Pharmaceutical Industries Ltd. Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid
WO2009001372A2 (en) 2007-06-25 2008-12-31 Manne Satyanarayana Reddy A novel process for the preparation of pregabalin
KR100846419B1 (ko) * 2007-08-10 2008-07-15 한국과학기술원 프레가발린의 신규한 제조 방법
WO2009046309A2 (en) * 2007-10-03 2009-04-09 Teva Pharmaceutical Industries Ltd. Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof
EP2053040A1 (en) * 2007-10-26 2009-04-29 Chemo Ibérica, S.A. Pregabalin intermediates and process for preparing them and Pregabalin
EP2225199A2 (en) * 2007-12-18 2010-09-08 Watson Pharma Private Limited Improved process for the preparation of (s)-pregabalin
EP2222630A1 (en) * 2007-12-26 2010-09-01 Generics (UK) Limited Processes to pregabalin
WO2009087941A1 (ja) * 2008-01-10 2009-07-16 Sumitomo Chemical Company, Limited シクロプロパンカルボン酸化合物の製造方法およびその中間体
EP2110372A1 (en) 2008-04-16 2009-10-21 Chemo Ibérica, S.A. Intermediates for the preparation of Pregabalin and process for their preparation
EP2116618A1 (en) 2008-05-09 2009-11-11 Agency for Science, Technology And Research Diagnosis and treatment of Kawasaki disease
WO2009141362A2 (en) 2008-05-21 2009-11-26 Sandoz Ag Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester
KR20100107500A (ko) * 2008-06-23 2010-10-05 테바 파마슈티컬 인더스트리즈 리미티드 (ｓ) 또는 (ｒ)-이소-부틸-글루타릭 에스테르의 입체선택적 효소 합성방법
WO2010070593A2 (en) 2008-12-19 2010-06-24 Pfizer Ireland Pharmaceuticals Malonate esters
CN101987826A (zh) * 2009-08-04 2011-03-23 铜陵凯顺生物科技有限公司 一种(3s)-3-氨甲基-5-甲基己酸的合成方法
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
US8212072B2 (en) 2010-08-13 2012-07-03 Divi's Laboratories, Ltd. Process for the preparation of pregabalin
WO2012025861A1 (en) * 2010-08-23 2012-03-01 Pfizer Manufacturing Ireland Process for the preparation of ( s ) - 3 - cyano - 5 - methylhexanoic acid derivatives adn of pregabalin
CN102464594B (zh) * 2010-11-17 2014-06-25 凯瑞斯德生化(苏州)有限公司 普瑞巴林的中间体化合物的制备方法
US9422230B2 (en) 2013-05-09 2016-08-23 Council Of Scientific And Industrial Research Process for the preparation of an anticonvulsant agent pregabalin hydrochloride
WO2016075082A1 (en) 2014-11-10 2016-05-19 Sandoz Ag Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam
WO2017019791A1 (en) 2015-07-27 2017-02-02 Teva Pharmaceuticals International Gmbh Synthesis of (s)-pregabalin

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS588390B2 (ja) * 1978-05-23 1983-02-15 住友化学工業株式会社 光学活性ω↓−シアノ↓−α↓−アシルアミノ酸誘導体の製造法
US4939288A (en) * 1989-01-23 1990-07-03 Monsanto Company Method of preparing (R)-succinic acid derivatives
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5171892A (en) * 1991-07-02 1992-12-15 E. I. Du Pont De Nemours And Company Chiral phospholanes via chiral 1,4-diol cyclic sulfates
US5616793A (en) 1995-06-02 1997-04-01 Warner-Lambert Company Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5637767A (en) * 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5840965A (en) * 1996-06-24 1998-11-24 E. I. Du Pont De Nemours And Company Process for the production of purified telephthalic acid
PL189872B1 (pl) * 1996-07-24 2005-10-31 Warner Lambert Co Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
US6127418A (en) * 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
AU1572399A (en) 1997-12-17 1999-07-05 Chirotech Technology Limited Asymmetric hydrogenation
WO1999052852A1 (en) 1998-04-09 1999-10-21 Chirotech Technology Limited Asymmetric hydrogenation
EP1250311B1 (en) * 2000-01-27 2004-03-17 Warner-Lambert Company Asymmetric synthesis of pregabalin

Also Published As

Publication number Publication date
SI1250311T1 (en) 2004-10-31
EE200200403A (et) 2003-10-15
BG106849A (en) 2003-03-31
JP4886753B2 (ja) 2012-02-29
ES2219493T3 (es) 2004-12-01
HU228815B1 (en) 2013-05-28
HN2001000010A (es) 2001-06-13
PT1250311E (pt) 2004-07-30
BG65560B1 (bg) 2008-12-30
TR200400953T4 (tr) 2004-07-21
MY127152A (en) 2006-11-30
NO327958B1 (no) 2009-10-26
OA12167A (en) 2006-05-08
BRPI0107863B8 (pt) 2017-04-25
PE20011063A1 (es) 2001-10-18
MA26869A1 (fr) 2004-12-20
DE60102356T2 (de) 2005-02-17
AP1438A (en) 2005-05-23
YU56202A (sh) 2006-01-16
HUP0204307A2 (hu) 2003-06-28
IL150633A (en) 2009-08-03
IS6430A (is) 2002-06-19
SV2002000295A (es) 2002-06-07
DZ3268A1 (fr) 2001-08-02
WO2001055090A1 (en) 2001-08-02
EP1250311B1 (en) 2004-03-17
DE60102356D1 (de) 2004-04-22
UA75584C2 (uk) 2006-05-15
CO5251411A1 (es) 2003-02-28
JP2003520841A (ja) 2003-07-08
EG24138A (en) 2008-08-06
US6891059B2 (en) 2005-05-10
KR100549748B1 (ko) 2006-02-08
HUP0204307A3 (en) 2003-07-28
EE05216B1 (et) 2009-10-15
EP1250311A1 (en) 2002-10-23
CR6703A (es) 2003-06-24
CZ302838B6 (cs) 2011-12-07
CN1396905A (zh) 2003-02-12
RS50257B (sr) 2009-07-15
MXPA02007307A (es) 2002-11-29
CA2396090A1 (en) 2001-08-02
AR028499A1 (es) 2003-05-14
CN1210253C (zh) 2005-07-13
TWI288128B (en) 2007-10-11
BR0107863A (pt) 2002-11-05
KR20020073187A (ko) 2002-09-19
ME00921B (me) 2012-06-20
NZ519551A (en) 2004-02-27
EA004934B1 (ru) 2004-10-28
SK10782002A3 (sk) 2002-11-06
PA8510501A1 (es) 2002-02-21
EA200200642A1 (ru) 2002-12-26
IS2038B (is) 2005-08-15
US20030212290A1 (en) 2003-11-13
CZ20022520A3 (cs) 2002-10-16
BR0107863B1 (pt) 2013-06-18
PL357077A1 (en) 2004-07-12
TNSN01016A1 (fr) 2005-11-10
JP4235384B2 (ja) 2009-03-11
SK287303B6 (sk) 2010-06-07
JP2009073841A (ja) 2009-04-09
ATE261930T1 (de) 2004-04-15
HRP20020627B1 (en) 2011-01-31
PL203985B1 (pl) 2009-11-30
GEP20043236B (en) 2004-05-25
AU777046B2 (en) 2004-09-30
CA2396090C (en) 2006-01-10
DK1250311T3 (da) 2004-08-16
HRP20020627A2 (en) 2004-08-31
NO20023582D0 (no) 2002-07-26
AP2002002588A0 (en) 2002-09-30
NO20023582L (no) 2002-09-02
CU23221A3 (es) 2007-07-20
CY2004011I1 (el) 2010-07-28
AU2213801A (en) 2001-08-07

Similar Documents

Publication Publication Date Title
HUP0204307A3 (en) Asymmetric synthesis of pregabalin
AU3467101A (en) Mucin synthesis inhibitors
GB0013241D0 (en) Voice synthesis
GB0100628D0 (en) Synthesis of tetramethylammonium hydroxide
MXPA03000914A (es) Sintesis de (r)-3-(4 -bromobencil) -1-(3, 5-diclorofenil) -5-yodo-3 -metil-1-h -imidazo[1, 2-a]imidazol -2-ona.
AU2001269685A1 (en) Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis
TW444674U (en) Improved structure of ornament
EP1372692A4 (en) ASYMMETRIC SYNTHESIS OF (S, S, R) - (-) - ACTINONE AND ITS ANALOG AND USES THEREOF
AU2132002A (en) Synthesis of small particles
GB0014876D0 (en) Chemical synthesis
GC0000267A (en) Asymmetric synthesis of pregabalin
GB0004699D0 (en) Chemical synthesis
HK1051679A1 (en) Asymmetric synthesis of pregabalin.
IL161608A0 (en) Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
GB0002333D0 (en) Compound synthesis
AU2001259381A1 (en) Synthesis of diphosphinoarenes
GB0030689D0 (en) Synthesis
GB0017055D0 (en) Synthesis
GB0015568D0 (en) Ester synthesis
GB0017074D0 (en) Ester synthesis
AU6715501A (en) Synthesis of cyclic compounds
AU2002357226A8 (en) The total synthesis of merrilactone a
GB0225106D0 (en) Synthesis of 3 hydroxy-5 -steroids
GB0016678D0 (en) Stereoselective chemical synthesis
GB0016571D0 (en) Stereoselective chemical synthesis